PharmedOut’s CME Conference, “Does Industry Influence Medical Discourse?” is scheduled for June 15 & 16 in the New Research Building Auditorium at Georgetown University Medical Center in Washington, D.C.
The conference is free for press.
Our conferences are known for intellectual stimulation, interdisciplinary fellowship, great networking, great food, and homemade cookies. New this year: craft beer!
The conference is accredited for 13.25 CME credits. More information is available here.
The latest schedule:
Thursday, June 15
8:15-8:45 a.m. Breakfast
8:45-9:00 Welcome and Opening Remarks
-
Edward B. Healton MD MPH, Georgetown University Medical Center, Executive Vice President for Health Sciences and Executive Dean, School of Medicine
-
Adriane Fugh-Berman MD, Georgetown University Medical Center
9:00-9:30 The Overuse of Orthopedic Procedures
-
James Rickert MD, Indiana University School of Medicine
9:30-10:00 Salespeople in the Surgical Suite
-
Bonnie O’Connor PhD, Brown University
10:00-10:30 Q&A/Discussion
-
Moderator: Tony Scialli MD, George Washington University
10:30-11:00 Break
11:00-11:30 Why Medical Researchers Stay Silent About Wrongdoings
-
Carl Elliott MD PhD, University of Minnesota
11:30-12:00 p.m. How the Prescription Drug Epidemic is a Symptom of a Faltering Healthcare System
-
Anna Lembke MD, Stanford School of Medicine
12:00-12:30 Q&A/Discussion
-
Moderator: E. Paige Boggs JD, Office of the Illinois Attorney General
12:30-1:45 Lunch
1:45-2:45 Abstract Slam: Student Presentations
Moderator: Bonnie O’Connor PhD, Brown University
-
Ethics of Participant Recruitment in Phase 1 Pharmaceutical Trials
-
CME and Pharmaceutical Industry Involvement
-
DCRx: A Model for Non-Industry Funded CME
-
Diabetes Drug Promotion in Washington DC
-
Binge Eating Disorder: An Example of Condition Branding
-
Is HbA1c a rational screening test for diabetes?
-
Are online CME modules on male hypogonadism accurate?
-
Differences in Reporting of Industry Funded Trials
2:45-3:00 PharmedOut: The First 10 Years
-
Adriane Fugh-Berman MD
3:00-3:30 Break
3:30-4:00 Myths and Realities about Why US Drugs Cost So Much
-
Joel Lexchin MD, York University
4:00-4:30 How Industry Influences Trade Discourse and Why It Matters
-
Ruth Lopert MD, George Washington University
4:30-5:00 Q&A/Discussion
-
Moderator: Marc Rodwin JD PhD, Suffolk Law School, Boston
5:00 Reception
Friday, June 16
8:15-8:45 a.m. Breakfast
8:45-9:00 Opening Remarks
-
Kenneth Dretchen PhD, Georgetown University Medical Center
-
Stephen Ray Mitchell MD MBA, Georgetown University School of Medicine
9:00-10:30 Pharma Funded Patient Advocacy Groups: Panel Discussion (Moderator: Adriane Fugh-Berman MD)
-
Sharon Batt PhD, Dalhousie University
-
Barbara Mintzes PhD, University of Sydney
-
Cindy Pearson, National Women’s Health Network
-
Susan Wood PhD, George Washington University
-
Phil Kucab MD, Detroit Medical Center
10:30-11:00 Break
11:00-11:30 A.D.H.D.: The Making of an American Epidemic
-
Alan Schwarz, New York, NY
11:30-12:00 p.m. Why Routine Screening for Depression May Be Bad for Your Health
-
Lisa Cosgrove PhD, University of Massachusetts
12:00-12:30 Q&A/Discussion
-
Moderator: Yulia Chentsova PhD, Georgetown University
12:30-1:30 Lunch
1:30-2:00 When Retractions Become Weapons
-
Ivan Oransky MD, Retraction Watch
2:00-2:30 Are Journalists Not Setting the Example/Agenda for COI Discussions?
-
Gary Schwitzer, HealthNewsReview
2:30-3:00 Q&A/Discussion
-
Moderator: Shannon Brownlee MS, Lown Institute
3:00-3:30 Break
3:30-4:00 The Limits of FDA-Approved Labeling and the Evolving Informational Needs of a Changing Healthcare System
-
Coleen Klasmeier JD, Partner, Sidley Austin LLP
4:00-4:30 Public Health Considerations in Off-label Promotion
-
Joshua Sharfstein MD, Johns Hopkins Bloomberg School of Public Health
4:30-5:00 Q&A/Discussion
-
Moderator: Robert Langreth, Bloomberg News
5:00 Conference Ends